Latest filing published 08 Dec 2022 for MAIA Biotechnology, Inc., €17k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Sergei Gryaznov: trading record in brief
All filings by Sergei Gryaznov on record concern MAIA Biotechnology, Inc. We count 3 filings; the first trade dates from 1 August 2022 and the latest from 7 December 2022.
Every open-market trade on record is a purchase: 1 purchase worth €15k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 option exercises.
The record was last updated on 8 December 2022 with an option exercise (€17k) in MAIA Biotechnology, Inc. The most recent open-market purchase was published on 2 August 2022, 1,561 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sergei Gryaznov
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$1.8334.9% of flowCommon StockSEC:0001127602-22-027093:0
- 10,000 shares@ US$1.8036.0% of flowCommon StockSEC:0000899243-22-029752:0
- 3,000 shares@ US$5.0029.1% of flowCommon StockSEC:0000899243-22-027455:0Canonical exit: 30 Oct 2022 (T+90)
3 of 3 declarations
